Bg pattern

PARLATOS 2.6 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use PARLATOS 2.6 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Prospectus

Parlatos 2.6 mg/ml oral solution

Dextromethorphan hydrobromide

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

Read the entire prospectus carefully before starting to take this medication, as it contains important information for you.

Follow the administration instructions for the medication contained in this prospectus or as indicated by your doctor or pharmacist exactly.

  • Keep this prospectus, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience adverse effects, consult your doctor or pharmacist, even if they are adverse effects that do not appear in this prospectus. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days of treatment, or if the cough is accompanied by high fever, skin rashes, or persistent headache.

Contents of the prospectus

  1. What Parlatos is and what it is used for
  2. What you need to know before starting to take Parlatos
  3. How to take Parlatos
  4. Possible adverse effects

5 Conservation of Parlatos

  1. Contents of the package and additional information

1. What Parlatos is and what it is used for

Dextromethorphan, the active ingredient of this medication, is a cough suppressant that inhibits the cough reflex.

It is indicated for the symptomatic treatment of cough that is not accompanied by expectoration (irritative cough, nervous cough) in adults and children from 2 years of age.

You should consult a doctor if it worsens or does not improve after 7 days of treatment.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to take Parlatos

Do not takeParlatos

  • If you are allergic to dextromethorphan or any of the other components of this medication (included in section 6).
  • In case of persistent or chronic cough, such as that due to tobacco, asthma, or chronic obstructive pulmonary disease (COPD), or when the cough is accompanied by abundant secretions.
  • Children under 2 years of age.
  • If you have bronchial asthma.
  • If you have chronic obstructive pulmonary disease (COPD).
  • If you have pneumonia.
  • If you have respiratory failure.
  • If you have respiratory depression.
  • If you are breastfeeding.
  • If you have a cough accompanied by abundant secretions (for example, in patients with diseases such as bronchiectasis (a lung disease where the bronchi are dilated and with pus) or cystic fibrosis).
  • If you are being treated or have been treated during the previous 2 weeks with any monoamine oxidase inhibitor (MAOI) medication used to treat depression, Parkinson's disease, or other diseases, as well as other serotonin reuptake inhibitor medications used to treat depression, such as fluoxetine and paroxetine; or also with bupropion, which is a medication used to quit smoking, or with linezolid, which is an antibacterial medication (see section on other medications).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Parlatos:

  • If you have persistent or chronic cough, such as that due to tobacco. Especially in children, chronic cough could be an early symptom of asthma.
  • If you are taking serotonergic medications (different from MAOIs) such as tricyclic antidepressants (see section on other medications and Parlatos).
  • In patients with neurological diseases associated with a notably reduced cough reflex (such as stroke, Parkinson's disease, and dementia), treatment with Parlatos should be administered with special caution and only after carefully evaluating the benefit-risk ratio (see section on other medications and Parlatos).
  • If you have liver or kidney disease.
  • If you have atopic dermatitis (an inflammatory skin disease characterized by erythema, itching, exudation, crusts, and scaling, which begins in childhood in individuals with a hereditary allergic predisposition) and/or mastocytosis (an increase in mast cells in the blood).
  • If you are sedated, debilitated, or bedridden.
  • Dextromethorphan has a mild addictive potential. Prolonged use (for example, if the recommended time period is exceeded) may produce tolerance or mental and physical dependence. People with a tendency to abuse or dependence should only take it under strict medical control and for short periods of time.
  • If you have respiratory failure
  • If you have a cough accompanied by expectoration

Patients with liver diseases should consult their doctor before using this medication.

There have been reports of abuse with medications containing dextromethorphan in adolescents; therefore, this possibility should be taken into account, as serious adverse effects may occur (see section "If you take more Parlatos than you should").

This medication may cause dependence. Therefore, treatment should be short-term.

Consult your doctor or pharmacist or nurse before taking Parlatos:

  • If you are taking other medications such as antidepressants or antipsychotics, Parlatos may interact with these medications, and you may experience changes in your mental state (e.g., agitation, hallucinations, coma) and other effects such as body temperature above 38°C, increased heart rate, high blood pressure, and exaggerated reflexes, muscle stiffness, lack of coordination, and/or gastrointestinal symptoms (e.g., nausea, vomiting, and diarrhea).

Pediatric population

Severe adverse effects may occur in children in case of overdose, including neurological alterations. Caregivers should not exceed the recommended dose.

Do not administer to children under 2 years of age.

Other medications and Parlatos

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication. Do not take this medication during treatment or in the 2 weeks following treatment with the following medications, as excitement, high blood pressure, and fever above 40°C (hyperpyrexia) may occur:

  • Monoamine oxidase inhibitor (MAOI) antidepressants (moclobemide, tranilcipromine).
  • Serotonin reuptake inhibitor antidepressants (such as fluoxetine or paroxetine).
  • Bupropion (used to quit smoking).
  • Linezolid (used as an antibacterial medication).
  • Procarbazine (used to treat cancer).
  • Selegiline (used to treat Parkinson's disease).
  • Terbinafine (used as an antifungal medication).

Before taking this medication, you should consult your doctor if you are using any of the following medications, as it may be necessary to modify the dose of one of them or interrupt treatment:

  • Medications to treat heart arrhythmias, such as amiodarone, quinidine, flecainide, and propafenone.
  • Anti-inflammatory medications, such as celecoxib, parecoxib, or valdecoxib.
  • Central nervous system depressant medications used to treat mental illnesses, allergies, or Parkinson's disease.
  • Medications used to eliminate phlegm and mucus, expectorants, and mucolytics, especially if you have a chest disease such as bronchiectasis (a lung disease where the bronchi are dilated and with pus) or cystic fibrosis.
  • Medications for the treatment of psychosis (states of mind in which there is a loss of contact with reality), such as haloperidol and thioridazine.
  • Medications for the treatment of HIV, such as ritonavir.
  • Plant-based medications, such as berberine.
  • Medications for the treatment of hyperparathyroidism, such as cinacalcet.
  • Antifungal medications, such as terbinafine.
  • Medications for the treatment of stomach acidity, such as cimetidine.

Taking Parlatos with food, drinks, and alcohol

Alcoholic beverages should not be consumed during treatment, as they may increase the occurrence of adverse effects.

Do not take with grapefruit or bitter orange juice, as they may increase the adverse effects of this medication.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Consult your doctor or pharmacist before using any medication. Women who are breastfeeding should not take this medication without consulting their doctor.

Women who are pregnant should not take this medication without consulting their doctor.

Driving and using machines

On rare occasions, during treatment, drowsiness and dizziness may occur, so if you notice these symptoms, you should not drive vehicles or operate hazardous machinery.

Parlatos contains sucrose, cochineal red A (E-124), and sodium

This medication contains sucrose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.

This medication may cause allergic reactions because it contains cochineal red A. It may cause asthma, especially in patients allergic to acetylsalicylic acid.

This medication contains less than 1 mmol of sodium (23 mg) per ml; that is, it is essentially "sodium-free".

3. How to take Parlatos

Follow the administration instructions for the medication indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

Adults and adolescents from 12 years of age: take 4 to 7 ml (equivalent to 10.4 mg - 19.5 mg of dextromethorphan hydrobromide), depending on the intensity of the cough, every 4-6 hours.

Do not exceed 6 daily doses.

The maximum amount that can be taken in 24 hours is 45 ml, divided into several doses.

Use in children

Children between 6-11 years of age: take 2 to 3.5 ml (equivalent to 5.2 mg - 9.1 mg of dextromethorphan hydrobromide), depending on the intensity of the cough, every 4-6 hours.

Do not exceed 6 daily doses.

The maximum amount that can be taken in 24 hours is 21 ml, divided into several doses.

Children between 2-5 years of age: take 1 to 1.5 ml (equivalent to 2.6 mg - 3.9 mg of dextromethorphan hydrobromide), depending on the intensity of the cough, every 4-6 hours.

Do not exceed 6 daily doses.

The maximum amount that can be taken in 24 hours is 9 ml, divided into several doses.

Children under 2 years of age:

This medication is contraindicated in children under 2 years of age.

How to take:

The medication is taken orally. Take the corresponding amount of oral solution, according to the recommended dose, measured with the help of the syringe included.

Do not exceed the recommended dose.

It can be taken with or without food.

Do not take with grapefruit or bitter orange juice or with alcoholic beverages (see section "Taking Parlatos with food, drinks, and alcohol").

If it worsens or if the cough persists for more than 7 days of treatment, or if it is accompanied by high fever, skin rashes, or persistent headache, consult your doctor.

If you take more Parlatos than you should

If you take more Parlatos than recommended, you may especially notice in children and adolescents or in case of abuse: nausea, vomiting, gastrointestinal discomfort, dizziness, fatigue, drowsiness, and hallucinations.

Similarly, restlessness and excitability can transform into agitation with increased overdose. Additionally, symptoms such as decreased concentration and consciousness up to coma as a symptom of severe intoxication, changes in mood such as dysphoria and euphoria, psychotic disorders such as disorientation and delirium up to confused or paranoid states, increased muscle tone, ataxia (uncoordinated movements), dysarthria, nystagmus (involuntary and uncontrolled eye movement), and visual disturbances, as well as respiratory depression, changes in blood pressure (high or low blood pressure), and tachycardia (accelerated heart rate) may occur.

Dextromethorphan may increase the risk of serotonin syndrome, and this risk is increased in cases of overdose, especially if taken with other serotonergic agents.

If you take more Parlatos than indicated, you may experience the following symptoms: nausea and vomiting, involuntary muscle contractions, agitation, confusion, drowsiness, consciousness disorders, involuntary and rapid eye movements, cardiac disorders (accelerated heart rate), coordination disorders, psychosis with visual hallucinations, and hyperexcitability.

Other symptoms in case of massive overdose may be: coma, severe respiratory problems, and convulsions.

Contact your doctor or hospital immediately if you experience any of the mentioned symptoms.

In cases of overdose or accidental ingestion, go immediately to a medical center or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take Parlatos

Do not take a double dose to make up for forgotten doses.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medications, this medication may cause adverse effects, although not all people experience them.

Frequent adverse effects: may affect up to one in ten patients.

  • Dizziness
  • Nausea
  • Vomiting
  • Gastrointestinal discomfort
  • Fatigue

Very rare adverse effects: may affect up to one in ten thousand patients.

  • Hallucinations
  • Drowsiness
  • Dependence in people who have abused dextromethorphan.

Adverse effects with unknown frequency (cannot be estimated from available data).

  • Hypersensitivity reactions, including anaphylactic reactions, angioedema, urticaria, pruritus, rash, and erythema.
  • Fixed drug eruption (FDE)
  • Mental confusion, headache, constipation.

Reporting adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Parlatos

Keep this medication out of the sight and reach of children.

Do not freeze

Do not use Parlatos after the expiration date that appears on the packaging after CAD:. The expiration date is the last day of the month indicated.

Medications should not be thrown away through the sewers or in the trash. Deposit the packaging and medications that you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications that you no longer need. This way, you will help protect the environment.

6. Contents of the package and additional information

Composition of Parlatos

The active ingredient is dextromethorphan hydrobromide. Each ml of oral solution contains 2.6 mg of dextromethorphan hydrobromide.

The other components (excipients) are:

Sucrose, sodium saccharin, sodium hydroxide, sorbic acid (E-200), disodium edetate, peppermint essence, cochineal red A (E-124), and water.

Appearance of the product and contents of the package

Bottle with 200 ml of oral solution. Each package is provided with a dosing syringe with a scale of 0.5 ml to 5 ml

Marketing authorization holder and manufacturer

Marketing authorization holder:

PHARMEX ADVANCED LABORATORIES, S.L.

Ctra. A-431 Km.19

14720 Almodóvar del Río (Córdoba)

Spain

Manufacturer:

PHARMEX ADVANCED LABORATORIES, S.L.

Ctra. A-431 Km.19

14720 Almodóvar del Río (Córdoba)

Spain

Date of the last revision of this prospectus:June 2022

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for PARLATOS 2.6 mg/ml ORAL SOLUTION

Discuss questions about PARLATOS 2.6 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Sviatoslav Chekhun

Oncology 13 years exp.

Dr. Sviatoslav Chekhun is a medical oncologist with international clinical and research experience, specializing in modern medical oncology and a personalized approach to cancer treatment.

Currently (since 2025), he works as a Medical Oncologist at Institut Català d’Oncologia (Girona, Spain). Previously, he completed his residency in Medical Oncology and was involved in clinical research at Hospital Universitari Germans Trias i Pujol.

Dr. Chekhun has a strong academic and scientific background. He served as a lecturer in Internal Medicine at O.O. Bohomolets National Medical University and conducted research in experimental oncology at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology.

Earlier in his career, he worked as a medical oncologist at the Kyiv City Clinical Oncological Center and contributed to regulatory evaluation of medicinal products at the State Expert Center of the Ministry of Health of Ukraine.

When to consult Dr. Chekhun:

  •  for diagnosis or clarification of a cancer diagnosis
  •  to obtain a second opinion on an existing treatment plan 
  •  when you need a personalized treatment strategy 
  •  for interpretation of test results, CT, MRI, PET-CT, and biopsies 
  •  when choosing between treatment options (chemotherapy, targeted therapy, immunotherapy) 
  •  in case of doubts about treatment strategy or disease progression 

Consultation format

Dr. Chekhun provides online consultations, where you can receive:

  •  expert second opinion 
  •  detailed case review 
  •  recommendations based on current international treatment guidelines 
  •  personalized treatment and follow-up plan 

Important:
Prescription and monitoring of medications must be carried out by your treating physician in an in-person (offline) setting. An online consultation does not replace a face-to-face visit but helps you make more informed decisions about your treatment.

Dr. Sviatoslav Chekhun combines clinical practice, research, and international experience, enabling him to provide patients with modern, evidence-based approaches in oncology.

5.0 (79)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

5.0 (195)
Doctor

Taisiia Proida

Family medicine 7 years exp.

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€66
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€86

Get PARLATOS 2.6 mg/ml ORAL SOLUTION Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for PARLATOS 2.6 mg/ml ORAL SOLUTION?

PARLATOS 2.6 mg/ml ORAL SOLUTION does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in PARLATOS 2.6 mg/ml ORAL SOLUTION?

The active ingredient in PARLATOS 2.6 mg/ml ORAL SOLUTION is dextromethorphan. This information helps identify medicines with the same composition but different brand names.

Who manufactures PARLATOS 2.6 mg/ml ORAL SOLUTION?

PARLATOS 2.6 mg/ml ORAL SOLUTION is manufactured by Pharmex Advanced Laboratories S.L.. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of PARLATOS 2.6 mg/ml ORAL SOLUTION online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether PARLATOS 2.6 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy PARLATOS 2.6 mg/ml ORAL SOLUTION in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy PARLATOS 2.6 mg/ml ORAL SOLUTION in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to PARLATOS 2.6 mg/ml ORAL SOLUTION?

Other medicines with the same active substance (dextromethorphan) include BICASAN 2 mg/ml SYRUP, BISOLVON ANTITUSSIVE 2 mg/ml SYRUP, CINFATOS 10 mg LOZENGES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media